Evidence map›Paper›PMID 24332445›Full record

Observational studyAtencion primaria2014

[Observational and cross-sectional study of prevalence and severity of the opioid-induced bowel dysfunction].

Rafael Gálvez, Mariano Provencio, Manuel Cobo, Cristina Pérez, Concha Pérez, Jaume Canal

Open access · goldAbstract readEnglish AbstractMulticenter StudyObservational Study
In one paragraph

Observational study in Atencion primaria, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Rafael GálvezUnidad de Dolor, Hospital Universitario Virgen de las Nieves, Granada, España. Electronic address: rafaelgalvez@hotmail.com.
Mariano ProvencioServicio de Oncología Médica, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.
Manuel CoboServicio de Oncología Médica, Complejo Hospitalario Regional Carlos Haya, Málaga, España.
Cristina PérezUnidad de Dolor, Hospital Universitario Miguel Servet, Zaragoza, España.
Concha PérezUnidad de Dolor, Hospital Universitario de La Princesa, Madrid, España.
Jaume CanalUnidad de Cuidados Paliativos, Hospital Universitari Arnau de Vilanova de Lleida, Lleida, España.
Hospital Universitario Miguel Servet · ESHospital Universitari Arnau de Vilanova · ESHospital Universitario Puerta de Hierro Majadahonda · ESHospital Universitario Virgen de las Nieves · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyze the prevalence and severity of the opioid-induced bowel dysfunction (OBD) symptoms.

designEpidemiological, observational and cross-sectional study. LOCATION: Six Spanish centers participated.

participantsA total of 317 outpatients with a diagnosis of cancer pain or non-cancer pain treated with a unique opioid were recruited. MAIN MEASUREMENTS: The prevalence of OBD symptoms was measured using a visual analog scale (VAS: 0-100), and constipation was also assessed by the Bowel Function Index (BFI). The treatment for gastrointestinal symptoms was recorded, and the frequency of symptoms between different opioid treatments was compared. Finally, quality of life was evaluated.

resultsThe prevalence of OBD with at least one gastrointestinal disorder was 94.6%, with constipation being the most frequent symptom (BFI: 91.6%; VAS: 90.2%) and nearly half of the patients showed three or more symptoms with a VAS ≥ 4. No significant differences were detected in the prevalence of symptoms between the opioid groups. A decrease in the wellbeing of patients was detected related to moderate to severe gastrointestinal symptoms.

conclusionsA high rate of gastrointestinal disorders probably related to OBD have been confirmed in patients on opioid therapy, highlighting the need for new drug strategies.

Indexed as

AdultAgedAged, 80 and overAnalgesics, OpioidChronic PainCross-Sectional StudiesFemaleGastrointestinal DiseasesHumansMaleMiddle AgedPrevalenceSeverity of Illness IndexAnalgesics, OpioidAbdominal painAnalgésicosAnalgesicsConstipationDolor abdominalEstreñimientoOpioidesOpioidsPrevalencePrevalencia

Identifiers

PMID24332445
PMCPMC6985603
OpenAlexW1994841913

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.